AstraZeneca extends oncology partnership with Proteros AstraZeneca has boosted its research capacity by extending its oncology partnership with Proteros biostructures. German pharma firm Proteros Share X AstraZeneca extends oncology partnership with Proteros https://pharmaphorum.com/news/astrazeneca-extends-oncology-partnership-with-proteros/
Accelerator aims to promote digital health innovation in Italy A digital health startup accelerator is launching in Italy, with more than €6 million backing the new enterprise. Share X Accelerator aims to promote digital health innovation in Italy https://pharmaphorum.com/digital/accelerator-aims-to-promote-digital-health-innovation-in-italy/
Novel drug to tackle inflammatory diseases begins trial An early-stage drug that is being developed to tackle inflammatory and autoimmune diseases has been approved by the Share X Novel drug to tackle inflammatory diseases begins trial https://pharmaphorum.com/news/novel-drug-to-tackle-inflammatory-diseases-begins-trial/
Do pharmaceutical businesses need to rethink what their graduate schemes offer? As the world and the UK continues its march out of the pandemic’s shadow, the pharmaceutical and life Share X Do pharmaceutical businesses need to rethink what their graduate schemes offer? https://pharmaphorum.com/views-and-analysis/do-pharmaceutical-businesses-need-to-rethink-what-their-graduate-schemes-offer/
Adding value through coaching Strategic coaching is bringing rewards across pharma as the industry adjusts to post-pandemic practices and challenges. Field forces Share X Adding value through coaching https://pharmaphorum.com/sales-marketing/adding-value-through-coaching/
USAID on expanding digital health globally – part one Adele Waugaman, senior digital health coordinator of the COVID-19 response at the United States Agency for International Development Share X USAID on expanding digital health globally – part one https://pharmaphorum.com/digital/usaid-on-expanding-digital-health-globally-part-one/
Deep Dive: Market Access For life science companies around the world, enabling faster access to innovative drugs and therapies is a complicated Share X Deep Dive: Market Access https://pharmaphorum.com/market-access-2/deep-dive-market-access-2022/
Emerging technologies that are changing the way healthcare is delivered in 2022 Wherever you consider the medical industry, you will find several new technologies being used to make new medicines, Share X Emerging technologies that are changing the way healthcare is delivered in 2022 https://pharmaphorum.com/r-d/emerging-technologies-that-are-changing-the-way-healthcare-is-delivered-in-2022/
Inside the changing tides of life science research Astellas Pharma chief medical officer Bernhardt Zeiher talks about the evolution of R&D in life sciences Research and Share X Inside the changing tides of life science research https://pharmaphorum.com/r-d/inside-the-changing-tides-of-life-science-research/
Medical Informatics and Rare Disease: a bridge between two worlds Share X Medical Informatics and Rare Disease: a bridge between two worlds https://pharmaphorum.com/webinars/medical-informatics-bridge-between-two-worlds-iqvia/
ICSs – an opportunity to improve Patient & Market Access at a local level Share X ICSs – an opportunity to improve Patient & Market Access at a local level https://pharmaphorum.com/webinars/integrated-care-systems-opportunity-to-improve-patient-market-access/
Is your digital communication strategy up to par? Share X Is your digital communication strategy up to par? https://pharmaphorum.com/webinars/is-your-digital-communication-strategy-up-to-par/
Achieving diversity, equity and inclusion in clinical trials Making sure clinical trials are diverse and representative of the populations they’re studying isn’t just the right thing Share X Achieving diversity, equity and inclusion in clinical trials https://pharmaphorum.com/r-d/achieving-diversity-equity-and-inclusion-in-clinical-trials/
How to identify and engage with digital opinion leaders The industry has long sought the insight and advice of revered, influential figures. Typically, these key opinion leaders Share X How to identify and engage with digital opinion leaders https://pharmaphorum.com/whitepapers/how-to-identify-and-engage-with-digital-opinion-leaders/
5 best practices for improving patient engagement Life science companies invest a significant number of resources to engage physicians and patient advocates. However, companies often Share X 5 best practices for improving patient engagement https://pharmaphorum.com/whitepapers/5-best-practices-improving-patient-engagement/
Innovative solutions to the drug pricing crisis: the pharmaphorum podcast Share X Innovative solutions to the drug pricing crisis: the pharmaphorum podcast https://pharmaphorum.com/podcast/innovative-solutions-to-the-drug-pricing-crisis-the-pharmaphorum-podcast/
Health Innovators – Amy Bucher Share X Health Innovators – Amy Bucher https://pharmaphorum.com/patients/health-innovators-amy-bucher/
Big data and how it can change the game in pharma: the pharmaphorum podcast Share X Big data and how it can change the game in pharma: the pharmaphorum podcast https://pharmaphorum.com/podcast/big-data-how-it-can-change-the-game-pharma-pharmaphorum-podcast/
Content Factory 24/7: Viseven adds a Center of Excellence in India to provide around-the-clock global support for its clients Share X Content Factory 24/7: Viseven adds a Center of Excellence in India to provide around-the-clock global support for its clients https://pharmaphorum.com/partner-content/content-factory-24-7-viseven-adds-a-center-of-excellence-in-india-to-provide-around-the-clock-global-support-for-its-clients/
4 Reasons Why You Shouldn’t Ignore CDISC Data Standards Share X 4 Reasons Why You Shouldn’t Ignore CDISC Data Standards https://pharmaphorum.com/partner-content/4-reasons-why-you-shouldnt-ignore-cdisc-data-standards/
How to Provide Value that Benefits Patients (and Your Brand) Share X How to Provide Value that Benefits Patients (and Your Brand) https://pharmaphorum.com/partner-content/how-to-provide-value-that-benefits-patients-and-your-brand/
The Difference Between KOL Identification And KOL Mapping Share X The Difference Between KOL Identification And KOL Mapping https://pharmaphorum.com/partner-content/the-difference-between-kol-identification-and-kol-mapping/
AXON hires a Global Healthcare Insights and Strategy Lead Share X AXON hires a Global Healthcare Insights and Strategy Lead https://pharmaphorum.com/partner-content/axon-hires-a-global-healthcare-insights-and-strategy-lead/
Performance-io hires Lonneke Feskens to lead Europe Share X Performance-io hires Lonneke Feskens to lead Europe https://pharmaphorum.com/partner-content/performance-io-hires-lonneke-feskens-to-lead-europe/
